Adam S DuVall (Adam Duvall, Adam DuVall)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Community Dwelling

Signaling Pathway

Monoclonal Antibody

Top Venues

International journal of environmental research and public health

JCO precision oncology

JCO oncology practice

Journal of assisted reproduction and genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn O'Keefe, Meiyan Chen, Kevin J Lesser, Adam S DuVall, Alexander T Dils
Treating Mental Health and Quality of Life in Older Cancer Patients with Cognitive Behavioral Therapy: A Systematic Review and Meta-Analysis. International journal of environmental research and public health 21 (7) (2024)
Kathryn O'Keefe, Meiyan Chen, Kevin J Lesser, Adam S DuVall, Alexander T Dils
Treating Mental Health and Quality of Life in Older Cancer Patients with Cognitive Behavioral Therapy: A Systematic Review and Meta-Analysis. International journal of environmental research and public health 21 (7) (2024)
Kathryn O'Keefe, Meiyan Chen, Kevin J Lesser, Adam S DuVall, Alexander T Dils
Treating Mental Health and Quality of Life in Older Cancer Patients with Cognitive Behavioral Therapy: A Systematic Review and Meta-Analysis. International journal of environmental research and public health 21 (7) (2024)
Allison C Rosenthal, Adam S DuVall, Justine M Kahn, Niloufer Khan
Disparities in care and outcomes for adolescent and young adult lymphoma patients. EJHaem 4 (4) (2023)
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, Bartholomew J Eisfelder, Anika T Thomas-Toth, Girish Venkataraman, Vijayalakshmi Ananthanarayanan, Tiffaney L Vincent, Adam S DuVall, Anand Ashwin Patel, Yi Chen, Fenlai Tan, Stephen P Anthony, Yu Chen, Yue Shen, Olatoyosi M Odenike, David Trent Teachey, Barbara L Kee, James L LaBelle, Wendy Stock
Dual targeting of apoptotic and signaling pathways in T-lineage acute lymphoblastic leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Adam S DuVall, Austin Wesevich, Richard A Larson
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma. Current hematologic malignancy reports (2023)
Adam S DuVall, Jori Sheade, Daniela Anderson, Samuel J Yates, Wendy Stock
Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered! JCO oncology practice 18 (7) (2022)
Sumiko Maristany, Adam S DuVall, Wendy Stock, Amanda J Adeleye
Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents. Journal of assisted reproduction and genetics 39 (8) (2022)
Juan Alban, Adam S DuVall, Sandeep K Gurbuxani, Wendy Stock, Anand Ashwin Patel
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. JCO precision oncology 6 (2022)